Who Paid My Doc
Natalie Neu
Pediatric Infectious Diseases New York, NY Medical Doctor
NPI 1235100173 CMS profile 568876
Columbia University Department Pediatrics, 3959 Broadway, New York, NY 10032
General payments
$2,100
Research payments
$3,750
Ownership & investment interest
$0
Research they led as principal investigator
$2,066
Through program year 2025, Natalie Neu of New York, NY is reported in the CMS Open Payments database as having received $2,100 across 2 general payments and $3,750 in research payments paid to them. Separately, studies naming them as principal investigator received $2,066 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 78th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,100 | 2 | |
| 2025 | Research | $2,400 | 2 | |
| 2021 | Research | $600 | 1 | |
| 2019 | Research | $750 | 1 |
Beside peers
- Natalie Neu
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Natalie Neu were reported at $2,100. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Natalie Neu | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $175 | $34–$2,175 | $163 |
| 2020 | $0 | $521 | $34–$6,009 | $114 |
| 2021 | $0 | $1,077 | $39–$4,557 | $132 |
| 2022 | $0 | $232 | $53–$6,196 | $149 |
| 2023 | $0 | $140 | $52–$4,662 | $160 |
| 2024 | $0 | $198 | $52–$3,860 | $164 |
| 2025 | $2,100 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 5 drugsPart D claims
71
Drug cost
$137,790
Branded share of claims
66.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | Brand | 21 | $92,607 | |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | Brand | 12 | $44,715 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 14 | $416 | |
| Ibuprofen | Generic | 11 | $36 | |
| Amlodipine Besylate | Generic | 13 | $16 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in New York
Joseph Domachowske
Pediatric Infectious Diseases · Syracuse, NY
Jana Shaw
Pediatric Infectious Diseases · Watertown, NY
Philip Larussa
Pediatric Infectious Diseases · New York, NY
Lisa Saiman
Pediatric Infectious Diseases · New York, NY
Leonard Krilov
Pediatric Infectious Diseases · Mineola, NY
Brenda Tesini
Pediatric Infectious Diseases · Rochester, NY
Related records
Pediatric Infectious Diseases in New York
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.